GMPS
GMP synthase [glutamine-hydrolyzing]
As of the edition of 20 October 2026, GMPS (GMP synthase [glutamine-hydrolyzing], UniProt P49915) has 1 drug tested at it and 4 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P49915
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Where it sits in the cell
- Inside the cell
- Solved structures
- 2
- Disease areas
- Immune system; Skin and connective tissue; Bones, joints and muscles; Pregnancy and women's health; Urinary and reproductive
- Registered trials of its drugs
- 6
Drugs at this target
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Mizoribine | Active | Phase 4 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Engaged | 4 |
| Total on the list | 4 |